Cabozantinib for advanced hepatocellular carcinoma

被引：2
|
作者：
Kudo, Masatoshi [1 ]
机构：
[1] Kindai Univ, Fac Med, Osaka, Japan
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2019年 / 8卷 / 02期
关键词：
SYSTEMIC THERAPY; DOUBLE-BLIND; REGORAFENIB; SORAFENIB; MULTICENTER; ANGIOGENESIS; PLACEBO; MET;
D O I：
10.21037/hbsn.2018.11.22
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：153 / 156
页数：4
相关论文
共 50 条
  • [1] Cabozantinib for advanced hepatocellular carcinoma
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (09): : 600 - 600
  • [2] Cabozantinib for advanced hepatocellular Carcinoma
    Alakus, Hakan
    Kuetting, Fabian
    Bruns, Christiane
    [J]. ONKOLOGE, 2018, 24 (11): : 924 - 926
  • [3] Cabozantinib: A Review in Advanced Hepatocellular Carcinoma
    Deeks, Emma D.
    [J]. TARGETED ONCOLOGY, 2019, 14 (01) : 107 - 113
  • [4] Cabozantinib: A Review in Advanced Hepatocellular Carcinoma
    Emma D. Deeks
    [J]. Targeted Oncology, 2019, 14 : 107 - 113
  • [5] Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
    Abou-Alfa, G. K.
    Meyer, T.
    Cheng, A. -L.
    El-Khoueiry, A. B.
    Rimassa, L.
    Ryoo, B. -Y.
    Cicin, I.
    Merle, P.
    Chen, Y. H.
    Park, J. -W.
    Blanc, J. -F.
    Bolondi, L.
    Klumpen, H. -J.
    Chan, S. L.
    Zagonel, V.
    Pressiani, T.
    Ryu, M. -H.
    Venook, A. P.
    Hessel, C.
    Borgman-Hagey, A. E.
    Schwab, G.
    Kelley, R. K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01): : 54 - 63
  • [6] Cabozantinib in the treatment of advanced hepatocellular carcinoma patients
    Klank-Sokolowska, Ewa
    Kucharewicz, Mariola
    Wojtukiewicz, Marek Z.
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2019, 15 (04): : 195 - 201
  • [7] Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular Carcinoma
    Storandt, Michael H.
    Gile, Jennifer J.
    Palmer, Mathias E.
    Zemla, Tyler J.
    Ahn, Daniel H.
    Bekaii-Saab, Tanios S.
    Jin, Zhaohui
    Tran, Nguyen H.
    Mahipal, Amit
    [J]. CANCERS, 2022, 14 (21)
  • [8] Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma
    Robin K. Kelley
    Patrick Mollon
    Jean-Frédéric Blanc
    Bruno Daniele
    Thomas Yau
    Ann-Lii Cheng
    Velichka Valcheva
    Florence Marteau
    Ines Guerra
    Ghassan K. Abou-Alfa
    [J]. Advances in Therapy, 2020, 37 : 2678 - 2695
  • [9] Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma
    Kelley, Robin K.
    Mollon, Patrick
    Blanc, Jean-Frederic
    Daniele, Bruno
    Yau, Thomas
    Cheng, Ann-Lii
    Valcheva, Velichka
    Marteau, Florence
    Guerra, Ines
    Abou-Alfa, Ghassan K.
    [J]. ADVANCES IN THERAPY, 2020, 37 (06) : 2678 - 2695
  • [10] Cabozantinib as a Second-Line Agent in Advanced Hepatocellular Carcinoma
    Kudo, Masatoshi
    [J]. LIVER CANCER, 2018, 7 (02) : 123 - 133
12345